SOPHiA GENETICS SA
SOPH
$5.17
-$0.02-0.39%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 21.71M | 19.46M | 18.32M | 17.78M | 17.73M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 21.71M | 19.46M | 18.32M | 17.78M | 17.73M |
| Cost of Revenue | 7.02M | 6.56M | 6.05M | 5.57M | 5.63M |
| Gross Profit | 14.69M | 12.91M | 12.27M | 12.21M | 12.10M |
| SG&A Expenses | 24.65M | 22.56M | 22.34M | 19.13M | 20.52M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 45.00K | 143.00K | -66.00K | -8.00K | -116.00K |
| Total Operating Expenses | 40.25M | 37.32M | 36.82M | 33.82M | 35.18M |
| Operating Income | -18.54M | -17.86M | -18.49M | -16.04M | -17.44M |
| Income Before Tax | -19.57M | -19.38M | -21.65M | -16.88M | -14.54M |
| Income Tax Expenses | -395.00K | 642.00K | 762.00K | 503.00K | 616.00K |
| Earnings from Continuing Operations | -19.18M | -20.02M | -22.41M | -17.39M | -15.16M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -19.18M | -20.02M | -22.41M | -17.39M | -15.16M |
| EBIT | -18.54M | -17.86M | -18.49M | -16.04M | -17.44M |
| EBITDA | -18.10M | -16.77M | -17.48M | -14.98M | -16.95M |
| EPS Basic | -0.28 | -0.30 | -0.33 | -0.26 | -0.23 |
| Normalized Basic EPS | -0.18 | -0.18 | -0.20 | -0.16 | -0.14 |
| EPS Diluted | -0.28 | -0.30 | -0.33 | -0.26 | -0.23 |
| Normalized Diluted EPS | -0.18 | -0.18 | -0.20 | -0.16 | -0.14 |
| Average Basic Shares Outstanding | 68.50M | 67.79M | 67.32M | 66.84M | 65.90M |
| Average Diluted Shares Outstanding | 68.50M | 67.79M | 67.32M | 66.84M | 65.90M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |